Dashboard
Dividend Tracker
My Portfolio
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
Oncosem Onkolojik Sistemler A.Ş. (ONCSM)
Market Closed
10 Aug, 15:00
XIST
All
(1)
TR
(1)
XIST
Primary
₺
241.
10
-0.6
-0.2482%
₺
5.99B
Market Cap
-
P/E Ratio
0.83%
Div Yield
283,206
Volume
0
Eps
₺
241.7
Previous Close
Watching
Watch
Add Transaction
Day Range
239.1
250.75
Year Range
106.9
389.75
Want to track
ONCSM
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Dividends
Statistics
Historical Data
Oncosem Onkolojik Sistemler A.Ş. (ONCSM) Statistics
Valuation metrics
Market Cap
5.99B
Enterprise value
6.03B
Trailing P/E (ttm)
118.96
Forward P/E
-
PEG ratio
-
Price/Sales (ttm)
8.44
Price/Book (mrq)
14.71
Enterprise Value/Revenue
8.5
Enterprise Value/EBITDA
28.98
Overview
Shares outstanding
23.85M
Float
4.4M
Shares short
-
% Held by insiders
0.64%
% Held by institutions
-
Average volume (10 days)
631.62K
Average volume (90 days)
836.97K
Price summary
52-Week low
106.9
52-Week high
389.75
Beta
0.85
50-Day moving average
281.85
200-Day moving average
196.15
Financials
Fiscal year
Fiscal year ends
31 Dec 2025
Most recent quarter (mrq)
31 Dec 2025
Profitability
Profit margin
0.07%
Operating margin
0.5%
Operational effectiveness
Return on assets
0.17%
Return on equity
0.13%
Income Statement
Revenue (ttm)
709.08M
Revenue per share (ttm)
29.73
Quarterly revenue growth (yoy)
0.55%
Gross profit (ttm)
319.83M
EBITDA
168.15M
Net income to common (ttm)
50.39M
Diluted EPS (ttm)
2.11
Quarterly earnings growth (yoy)
0.92%
Balance Sheet
Total cash (mrq)
45.38M
Total cash per share (mrq)
1.9
Total debt (mrq)
86.83M
Total Debt/Equity (mrq)
21.33
Current ratio (mrq)
2.61%
Book value per share (mrq)
17.07
Cash Flow
Cash flow statement
69.36M
Levered free cash flow (LFCF)
-29.37M